Cargando…

Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse

Chronic migraine patients are at risk of developing a medication overuse. Brain functional studies in these patients have demonstrated an orbitofrontal hypometabolism, persistent after overuse cessation. Orbitofrontal dysfunction is also present in addiction and thus could predispose migraineurs to...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez-Beldarrain, Marian, Carrasco, María, Bilbao, Amaia, García-Moncó, Juan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139058/
https://www.ncbi.nlm.nih.gov/pubmed/21499917
http://dx.doi.org/10.1007/s10194-011-0340-6
_version_ 1782208418373697536
author Gómez-Beldarrain, Marian
Carrasco, María
Bilbao, Amaia
García-Moncó, Juan C.
author_facet Gómez-Beldarrain, Marian
Carrasco, María
Bilbao, Amaia
García-Moncó, Juan C.
author_sort Gómez-Beldarrain, Marian
collection PubMed
description Chronic migraine patients are at risk of developing a medication overuse. Brain functional studies in these patients have demonstrated an orbitofrontal hypometabolism, persistent after overuse cessation. Orbitofrontal dysfunction is also present in addiction and thus could predispose migraineurs to medication overuse. The aim of this study was to investigate if orbitofrontal dysfunction can be demonstrated in patients with chronic migraine and medication overuse by performing a systematic neuropsychological evaluation focused on tests that assess frontal lobe function. Second, to establish whether it is related to the outcome of these patients. We prospectively studied 42 chronic migraine patients with medication overuse, 42 episodic migraineurs and 41 controls on a battery of neuropsychological tasks evaluating the orbitofrontal and dorsolateral functioning. Depression, anxiety, and personality traits were also assessed. Chronic migraineurs with medication overuse showed a significant impairment in orbitofrontal task performance and higher depression scores as compared to episodic migraineurs and controls. Dorsolateral dysfunction was present in both groups of migraneurs, who also had higher rates of anxiety as compared to controls. After 1 year of follow-up, migraine patient’s outcome was classified according to their medication overuse status. A negative outcome that included persistent or new-onset medication overuse was present in 34% of migraineurs and was associated with baseline poor orbitofrontal task performance, and with mild dorsolateral dysfunction, higher rates of depression, anxiety and neuroticism-anxiety traits. Formal education and years with migraine did not influence outcome. Orbitofrontal dysfunction is present in patients with chronic migraine and medication overuse, and associates with a poor outcome at 1 year of follow-up. Neuropsychological evaluation in migraine may help to detect patients prone to overuse so that appropriate therapeutic attitudes can be taken. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10194-011-0340-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-3139058
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-31390582011-08-26 Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse Gómez-Beldarrain, Marian Carrasco, María Bilbao, Amaia García-Moncó, Juan C. J Headache Pain Original Chronic migraine patients are at risk of developing a medication overuse. Brain functional studies in these patients have demonstrated an orbitofrontal hypometabolism, persistent after overuse cessation. Orbitofrontal dysfunction is also present in addiction and thus could predispose migraineurs to medication overuse. The aim of this study was to investigate if orbitofrontal dysfunction can be demonstrated in patients with chronic migraine and medication overuse by performing a systematic neuropsychological evaluation focused on tests that assess frontal lobe function. Second, to establish whether it is related to the outcome of these patients. We prospectively studied 42 chronic migraine patients with medication overuse, 42 episodic migraineurs and 41 controls on a battery of neuropsychological tasks evaluating the orbitofrontal and dorsolateral functioning. Depression, anxiety, and personality traits were also assessed. Chronic migraineurs with medication overuse showed a significant impairment in orbitofrontal task performance and higher depression scores as compared to episodic migraineurs and controls. Dorsolateral dysfunction was present in both groups of migraneurs, who also had higher rates of anxiety as compared to controls. After 1 year of follow-up, migraine patient’s outcome was classified according to their medication overuse status. A negative outcome that included persistent or new-onset medication overuse was present in 34% of migraineurs and was associated with baseline poor orbitofrontal task performance, and with mild dorsolateral dysfunction, higher rates of depression, anxiety and neuroticism-anxiety traits. Formal education and years with migraine did not influence outcome. Orbitofrontal dysfunction is present in patients with chronic migraine and medication overuse, and associates with a poor outcome at 1 year of follow-up. Neuropsychological evaluation in migraine may help to detect patients prone to overuse so that appropriate therapeutic attitudes can be taken. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s10194-011-0340-6) contains supplementary material, which is available to authorized users. Springer Milan 2011-04-17 /pmc/articles/PMC3139058/ /pubmed/21499917 http://dx.doi.org/10.1007/s10194-011-0340-6 Text en © The Author(s) 2011 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Original
Gómez-Beldarrain, Marian
Carrasco, María
Bilbao, Amaia
García-Moncó, Juan C.
Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse
title Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse
title_full Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse
title_fullStr Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse
title_full_unstemmed Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse
title_short Orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse
title_sort orbitofrontal dysfunction predicts poor prognosis in chronic migraine with medication overuse
topic Original
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139058/
https://www.ncbi.nlm.nih.gov/pubmed/21499917
http://dx.doi.org/10.1007/s10194-011-0340-6
work_keys_str_mv AT gomezbeldarrainmarian orbitofrontaldysfunctionpredictspoorprognosisinchronicmigrainewithmedicationoveruse
AT carrascomaria orbitofrontaldysfunctionpredictspoorprognosisinchronicmigrainewithmedicationoveruse
AT bilbaoamaia orbitofrontaldysfunctionpredictspoorprognosisinchronicmigrainewithmedicationoveruse
AT garciamoncojuanc orbitofrontaldysfunctionpredictspoorprognosisinchronicmigrainewithmedicationoveruse